spacer
home > ebr > spring 2002 > donation of organs and tissues - new legislation in finland on the prerequisites for medical research
PUBLICATIONS
European Biopharmaceutical Review

Donation of Organs and Tissues - New Legislation in Finland on the Prerequisites for Medical Research

The protection of and right to human organs, tissues and genomics in medical research is an increasingly discussed topic and it gives rise not only to reforms of legislation but also to ethical debate. The ratification of the Convention of Human Rights and Biomedicine (1) in 1997 required some changes to the then existing legislation in Finland, but at the same time it was considered necessary to reform the legislation on human organs and tissues in medical research as a whole. In addition, other international conventions, such as the United Nations Convention on Civil and Political Rights (2), put pressure on the national legislation of human organs and tissues in medical research.The most recent considerable reform in Finland in relation to biosciences law was the introduction of the Act on Medical Use of Human Organs and Tissues in 2001. The new legislation will certainly influence the future of the medical use of human organs and tissues in Finland, both from a contractual and a practical point of view.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Rainer Hilli, Partner, and Liisa Laurila, Lawyer, at Roschier Holmberg, Attorneys Ltd

Rainer Hilli is a Partner at Roschier Holmberg and is responsible for the company's technology, media and competition group, specialising mainly in matters relating to copyright, patents, trademarks, designs, computer law, telecommunications law, media law, market law and the life sciences.
Rainer's experience includes multi-jurisdictional IP litigation and IP-driven acquisitions. He is a frequent speaker and writer of articles in the field of intellectual property.
Liisa Laurila, MSc (Econ), LLM, works as a Lawyer for Roschier Holmberg in the technology, media and competition practice group. Liisa is a member of the firm's pharmaceutical and biosciences specialist team.
She advises on copyright and trademarks as well as on general corporate matters. Liisa specialises in data protection and life sciences law, and her working languages are Finnish, Swedish and English.

spacer
Rainer Hilli
spacer
spacer
spacer
Liisa Laurila
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’

CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says favourable conditions in the UAE are resulting in a boom of pharmaceutical manufacturing throughout the region. Government incentive schemes to increase domestic production, coupled with a brand friendly environment and rising healthcare needs is fuelling surging demand – with many new companies and plants launching in the last two years alone.
More info >>

White Papers

Modular Feeding Systems for Prefilled Syringes and Injection Devices

Dividella

The pre-filled syringe and injection device is an increasingly attractive presentation for both new and established parenteral pharmaceuticals. We will explore how innovative carton packaging solutions can enhance this presentation whilst meeting the stringent requirements of product protection.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement